 | • レポートコード：GIR-107A14283 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、過免疫血清のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。過免疫血清の種類別市場規模（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他）、用途別市場規模（政府機関、民用、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・過免疫血清の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他 ・用途別分析2016年-2026年：政府機関、民用、その他 ・過免疫血清の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・過免疫血清のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・過免疫血清のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・過免疫血清の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・過免疫血清の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hyperimmune Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hyperimmune Serum size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hyperimmune Serum market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hyperimmune Serum market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market segment by Application can be divided into
Government Institutions
Private Sector
Other
The key market players for global Hyperimmune Serum market are listed below:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hyperimmune Serum product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyperimmune Serum, with price, sales, revenue and global market share of Hyperimmune Serum from 2019 to 2021.
Chapter 3, the Hyperimmune Serum competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyperimmune Serum breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hyperimmune Serum market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hyperimmune Serum sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hyperimmune Serum Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hyperimmune Serum Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Hyperimmune Serum Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hyperimmune Serum Market Size & Forecast
1.4.1 Global Hyperimmune Serum Sales in Value (2016-2026))
1.4.2 Global Hyperimmune Serum Sales in Volume (2016-2026)
1.4.3 Global Hyperimmune Serum Price by Type (2016-2026) & (US$/Ton)
1.5 Global Hyperimmune Serum Production Capacity Analysis
1.5.1 Global Hyperimmune Serum Total Production Capacity (2016-2026)
1.5.2 Global Hyperimmune Serum Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hyperimmune Serum Market Drivers
1.6.2 Hyperimmune Serum Market Restraints
1.6.3 Hyperimmune Serum Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Hyperimmune Serum Product and Services
2.1.4 CSL Behring Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Hyperimmune Serum Product and Services
2.2.4 Grifols Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biotest
2.3.1 Biotest Details
2.3.2 Biotest Major Business
2.3.3 Biotest Hyperimmune Serum Product and Services
2.3.4 Biotest Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Kedrion
2.4.1 Kedrion Details
2.4.2 Kedrion Major Business
2.4.3 Kedrion Hyperimmune Serum Product and Services
2.4.4 Kedrion Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 CBPO
2.5.1 CBPO Details
2.5.2 CBPO Major Business
2.5.3 CBPO Hyperimmune Serum Product and Services
2.5.4 CBPO Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Emergent (Cangene)
2.6.1 Emergent (Cangene) Details
2.6.2 Emergent (Cangene) Major Business
2.6.3 Emergent (Cangene) Hyperimmune Serum Product and Services
2.6.4 Emergent (Cangene) Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Kamada
2.7.1 Kamada Details
2.7.2 Kamada Major Business
2.7.3 Kamada Hyperimmune Serum Product and Services
2.7.4 Kamada Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Hyperimmune Serum Product and Services
2.8.4 CNBG Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hualan Bio
2.9.1 Hualan Bio Details
2.9.2 Hualan Bio Major Business
2.9.3 Hualan Bio Hyperimmune Serum Product and Services
2.9.4 Hualan Bio Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Hyperimmune Serum Product and Services
2.10.4 Shanghai RAAS Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business
2.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Product and Services
2.11.4 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business
2.12.3 ADMA Biologics Hyperimmune Serum Product and Services
2.12.4 ADMA Biologics Hyperimmune Serum Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Hyperimmune Serum Sales by Manufacturer
3.1 Global Hyperimmune Serum Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hyperimmune Serum Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hyperimmune Serum
3.4 Market Concentration Rate
3.4.1 Top 3 Hyperimmune Serum Manufacturer Market Share
3.4.2 Top 6 Hyperimmune Serum Manufacturer Market Share
3.5 Global Hyperimmune Serum Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hyperimmune Serum Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hyperimmune Serum Market Size by Region
4.1.1 Global Hyperimmune Serum Sales in Volume by Region (2016-2026)
4.1.2 Global Hyperimmune Serum Revenue by Region (2016-2026)
4.2 North America Hyperimmune Serum Revenue (2016-2026)
4.3 Europe Hyperimmune Serum Revenue (2016-2026)
4.4 Asia-Pacific Hyperimmune Serum Revenue (2016-2026)
4.5 South America Hyperimmune Serum Revenue (2016-2026)
4.6 Middle East and Africa Hyperimmune Serum Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hyperimmune Serum Sales in Volume by Type (2016-2026)
5.2 Global Hyperimmune Serum Revenue by Type (2016-2026)
5.3 Global Hyperimmune Serum Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hyperimmune Serum Sales in Volume by Application (2016-2026)
6.2 Global Hyperimmune Serum Revenue by Application (2016-2026)
6.3 Global Hyperimmune Serum Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hyperimmune Serum Sales by Type (2016-2026)
7.2 North America Hyperimmune Serum Sales by Application (2016-2026)
7.3 North America Hyperimmune Serum Market Size by Country
7.3.1 North America Hyperimmune Serum Sales in Volume by Country (2016-2026)
7.3.2 North America Hyperimmune Serum Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hyperimmune Serum Sales by Type (2016-2026)
8.2 Europe Hyperimmune Serum Sales by Application (2016-2026)
8.3 Europe Hyperimmune Serum Market Size by Country
8.3.1 Europe Hyperimmune Serum Sales in Volume by Country (2016-2026)
8.3.2 Europe Hyperimmune Serum Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hyperimmune Serum Sales by Type (2016-2026)
9.2 Asia-Pacific Hyperimmune Serum Sales by Application (2016-2026)
9.3 Asia-Pacific Hyperimmune Serum Market Size by Region
9.3.1 Asia-Pacific Hyperimmune Serum Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hyperimmune Serum Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hyperimmune Serum Sales by Type (2016-2026)
10.2 South America Hyperimmune Serum Sales by Application (2016-2026)
10.3 South America Hyperimmune Serum Market Size by Country
10.3.1 South America Hyperimmune Serum Sales in Volume by Country (2016-2026)
10.3.2 South America Hyperimmune Serum Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hyperimmune Serum Sales by Type (2016-2026)
11.2 Middle East & Africa Hyperimmune Serum Sales by Application (2016-2026)
11.3 Middle East & Africa Hyperimmune Serum Market Size by Country
11.3.1 Middle East & Africa Hyperimmune Serum Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hyperimmune Serum Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hyperimmune Serum Typical Distributors
12.3 Hyperimmune Serum Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Hyperimmune Serum Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hyperimmune Serum Revenue by Application, (USD Million), 2021-2026
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Hyperimmune Serum Product and Services
Table 6. CSL Behring Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Major Business
Table 9. Grifols Hyperimmune Serum Product and Services
Table 10. Grifols Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biotest Basic Information, Manufacturing Base and Competitors
Table 12. Biotest Major Business
Table 13. Biotest Hyperimmune Serum Product and Services
Table 14. Biotest Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Kedrion Basic Information, Manufacturing Base and Competitors
Table 16. Kedrion Major Business
Table 17. Kedrion Hyperimmune Serum Product and Services
Table 18. Kedrion Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CBPO Basic Information, Manufacturing Base and Competitors
Table 20. CBPO Major Business
Table 21. CBPO Hyperimmune Serum Product and Services
Table 22. CBPO Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
Table 24. Emergent (Cangene) Major Business
Table 25. Emergent (Cangene) Hyperimmune Serum Product and Services
Table 26. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Kamada Basic Information, Manufacturing Base and Competitors
Table 28. Kamada Major Business
Table 29. Kamada Hyperimmune Serum Product and Services
Table 30. Kamada Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. CNBG Basic Information, Manufacturing Base and Competitors
Table 32. CNBG Major Business
Table 33. CNBG Hyperimmune Serum Product and Services
Table 34. CNBG Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 36. Hualan Bio Major Business
Table 37. Hualan Bio Hyperimmune Serum Product and Services
Table 38. Hualan Bio Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 40. Shanghai RAAS Major Business
Table 41. Shanghai RAAS Hyperimmune Serum Product and Services
Table 42. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 44. Sichuan Yuanda Shuyang Major Business
Table 45. Sichuan Yuanda Shuyang Hyperimmune Serum Product and Services
Table 46. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 48. ADMA Biologics Major Business
Table 49. ADMA Biologics Hyperimmune Serum Product and Services
Table 50. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Hyperimmune Serum Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 52. Global Hyperimmune Serum Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Hyperimmune Serum, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Hyperimmune Serum Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 55. Head Office and Hyperimmune Serum Production Site of Key Manufacturer
Table 56. Hyperimmune Serum New Entrant and Capacity Expansion Plans
Table 57. Hyperimmune Serum Mergers & Acquisitions in the Past Five Years
Table 58. Global Hyperimmune Serum Sales by Region (2016-2021e) & (Kiloton)
Table 59. Global Hyperimmune Serum Sales by Region (2021-2026) & (Kiloton)
Table 60. Global Hyperimmune Serum Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Hyperimmune Serum Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 63. Global Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 64. Global Hyperimmune Serum Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Hyperimmune Serum Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Hyperimmune Serum Price by Type (2016-2021e) & (US$/Ton)
Table 67. Global Hyperimmune Serum Price by Type (2021-2026) & (US$/Ton)
Table 68. Global Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 69. Global Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 70. Global Hyperimmune Serum Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Hyperimmune Serum Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Hyperimmune Serum Price by Application (2016-2021e) & (US$/Ton)
Table 73. Global Hyperimmune Serum Price by Application (2021-2026) & (US$/Ton)
Table 74. North America Hyperimmune Serum Sales by Country (2016-2021e) & (Kiloton)
Table 75. North America Hyperimmune Serum Sales by Country (2021-2026) & (Kiloton)
Table 76. North America Hyperimmune Serum Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Hyperimmune Serum Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 79. North America Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 80. North America Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 81. North America Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 82. Europe Hyperimmune Serum Sales by Country (2016-2021e) & (Kiloton)
Table 83. Europe Hyperimmune Serum Sales by Country (2021-2026) & (Kiloton)
Table 84. Europe Hyperimmune Serum Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Hyperimmune Serum Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 87. Europe Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 88. Europe Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 89. Europe Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 90. Asia-Pacific Hyperimmune Serum Sales by Region (2016-2021e) & (Kiloton)
Table 91. Asia-Pacific Hyperimmune Serum Sales by Region (2021-2026) & (Kiloton)
Table 92. Asia-Pacific Hyperimmune Serum Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Hyperimmune Serum Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 95. Asia-Pacific Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 96. Asia-Pacific Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 97. Asia-Pacific Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 98. South America Hyperimmune Serum Sales by Country (2016-2021e) & (Kiloton)
Table 99. South America Hyperimmune Serum Sales by Country (2021-2026) & (Kiloton)
Table 100. South America Hyperimmune Serum Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Hyperimmune Serum Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 103. South America Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 104. South America Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 105. South America Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 106. Middle East & Africa Hyperimmune Serum Sales by Country (2016-2021e) & (Kiloton)
Table 107. Middle East & Africa Hyperimmune Serum Sales by Country (2021-2026) & (Kiloton)
Table 108. Middle East & Africa Hyperimmune Serum Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Hyperimmune Serum Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Hyperimmune Serum Sales by Type (2016-2021e) & (Kiloton)
Table 111. Middle East & Africa Hyperimmune Serum Sales by Type (2021-2026) & (Kiloton)
Table 112. Middle East & Africa Hyperimmune Serum Sales by Application (2016-2021e) & (Kiloton)
Table 113. Middle East & Africa Hyperimmune Serum Sales by Application (2021-2026) & (Kiloton)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Hyperimmune Serum Typical Distributors
Table 117. Hyperimmune Serum Typical Customers
List of Figures
Figure 1. Hyperimmune Serum Picture
Figure 2. Global Hyperimmune Serum Sales Market Share by Type in 2020
Figure 3. Hepatitis B Immunoglobulins
Figure 4. Rabies Immunoglobulins
Figure 5. Tetanus Immunoglobulins
Figure 6. Rho(D) Immunoglobulins
Figure 7. Other
Figure 8. Global Hyperimmune Serum Sales Market Share by Application in 2020
Figure 9. Government Institutions
Figure 10. Private Sector
Figure 11. Other
Figure 12. Global Hyperimmune Serum Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 13. Global Hyperimmune Serum Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Hyperimmune Serum Sales (2016-2026) & (Kiloton)
Figure 15. Global Hyperimmune Serum Price by Type (2016-2026) & (US$/Ton)
Figure 16. Global Hyperimmune Serum Production Capacity (2016-2026) & (Kiloton)
Figure 17. Global Hyperimmune Serum Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Hyperimmune Serum Market Drivers
Figure 19. Hyperimmune Serum Market Restraints
Figure 20. Hyperimmune Serum Market Trends
Figure 21. Global Hyperimmune Serum Sales Market Share by Manufacturer in 2020
Figure 22. Global Hyperimmune Serum Revenue Market Share by Manufacturer in 2020
Figure 23. Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Hyperimmune Serum Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Hyperimmune Serum Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Hyperimmune Serum Sales Market Share by Region (2016-2026)
Figure 27. Global Hyperimmune Serum Revenue Market Share by Region (2016-2026)
Figure 28. North America Hyperimmune Serum Revenue (2016-2026) & (USD Million)
Figure 29. Europe Hyperimmune Serum Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Hyperimmune Serum Revenue (2016-2026) & (USD Million)
Figure 31. South America Hyperimmune Serum Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Hyperimmune Serum Revenue (2016-2026) & (USD Million)
Figure 33. Global Hyperimmune Serum Sales Market Share by Type (2016-2026)
Figure 34. Global Hyperimmune Serum Revenue Market Share by Type (2016-2026)
Figure 35. Global Hyperimmune Serum Price by Type (2016-2026) & (US$/Ton)
Figure 36. Global Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 37. Global Hyperimmune Serum Revenue Market Share by Application (2016-2026)
Figure 38. Global Hyperimmune Serum Price by Application (2016-2026) & (US$/Ton)
Figure 39. North America Hyperimmune Serum Sales Market Share by Type (2016-2026)
Figure 40. North America Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 41. North America Hyperimmune Serum Sales Market Share by Country (2016-2026)
Figure 42. North America Hyperimmune Serum Revenue Market Share by Country (2016-2026)
Figure 43. United States Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Hyperimmune Serum Sales Market Share by Type (2016-2026)
Figure 47. Europe Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 48. Europe Hyperimmune Serum Sales Market Share by Country (2016-2026)
Figure 49. Europe Hyperimmune Serum Revenue Market Share by Country (2016-2026)
Figure 50. Germany Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Hyperimmune Serum Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Hyperimmune Serum Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Hyperimmune Serum Revenue Market Share by Region (2016-2026)
Figure 59. China Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Hyperimmune Serum Sales Market Share by Type (2016-2026)
Figure 66. South America Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 67. South America Hyperimmune Serum Sales Market Share by Country (2016-2026)
Figure 68. South America Hyperimmune Serum Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Hyperimmune Serum Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Hyperimmune Serum Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Hyperimmune Serum Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Hyperimmune Serum Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Hyperimmune Serum Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の高度免疫グロブリン市場予測（～2024年） Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, var…- 世界の血清分離管市場 2021：企業別、地域別、種類・用途別 The Serum Separation Tube market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の新生ウシ血清市場 2021：企業別、地域別、種類・用途別 The Newborn Bovine Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のフォーミュラフィードウシ血清市場 2021：企業別、地域別、種類・用途別 The Formula Fed Bovine Serum market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のウシ胎児血清（FCS）市場 2021：企業別、地域別、種類・用途別 The Fetal Calf Serum (FCS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…